Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT07866872
Status
Enrolling By Invitation

Conditions

  • End Stage Renal Disease (ESRD)
  • Volume Overload

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Relative Blood Volume Monitoring (RBVM) — DEVICE
    The intervention of interest for this prospective study is guidance obtained by relative blood volume monitoring (RBVM) using the Crit-Line IV Monitor or CLiC device. The application of RBVM versus no application of RBVM during inpatient hemodialysis sessions will be according to the standard of care at the participating hospital.

Study Details

The investigators are examining how adding relative blood volume monitoring (RBVM) to the best clinical practice affects outcomes (length of stay and rehospitalization) among dialysis patients hospitalized for or with volume overload.

Key Dates

First listed
Oct 8, 2026
Start date
Jun 17, 2026
Status verified
Oct 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: RBVM patients
    Patients from hospital where relative blood volume monitoring for inpatient hemodialysis sessions
  • Arm: Non RBVM Patients
    Patients from hospital where relative blood volume monitoring not applied for inpatient hemodialysis sessions

Primary Outcome Measure

Length of Index Hospitalization [ Time Frame: From the date of hospitalization to the date of discharge whichever comes first assessed up to 365 days ]

Locations (2)

FacilityCityStateZIPSite coordinators
Brigham and Women's HospitalBostonMassachusetts02115-
Massachusetts General HospitalBostonMassachusetts02114-

Find similar trials in Boston, MA

By research site
Brigham and Women's Hospital· Boston, MAMassachusetts General Hospital· Boston, MA

Related Studies